Expression spectrum of melanoma antigen-encoding gene family members in colorectal carcinoma

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 6, 1998, Pages 551-554

  Hasegawa, Hirofumi ^a   Mori, Masaki ^a   Haraguchi, Masaru ^a   Ueo, Hiroaki ^b   Sugimachi, Keizo ^c   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA PREFECTURAL HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER STAGING; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENE THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; MULTIGENE FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; COLON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DNA PRIMERS; FEMALE; HUMANS; MALE; MULTIGENE FAMILY; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0031777444     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphcytes on a human melanoma. Science. 1991;254:1643-1647.
2. De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics. 1994;40: 360-369.
3. Gaugler B, Van den Eynde B, van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med. 1994;179:921-930.
4. Weynants P, Lethe B, Brasseur F, Marchand M, Boon T. Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer. 1994;56:826-829.
5. Brasseur F, Marchand M, Vanwijck R, et al. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer, 1992;52:839-841. Letter.
6. Rimoldi D, Romero P, Carrel S. The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumor cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer. 1993;54:527-528. Letter.
7. Shichijo S, Tsunosue R, Masuoka K, et al. Expression of the MAGE gene family in human lymphocytic leukemia. Cancer Immunol Immunother. 1995;41: 90-103.
8. Patard JJ, Brasseur F, Gil DS, et al. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer. 1995;64:60-64.
9. Inoue H, Mori M, Honda M, et al. The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma. Gastroenterology. 1995;109:1522-1525.
10. Li JYY, Fujie T, Baba K, Ueo H, Mori M, Akiyoshi T. The expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin Cancer Res. 1996;2:1619-1625.
11. Mori M, Inoue H, Mimori K, et al. Expression of MAGE genes in human colorectal carcinoma. Ann Surg. 1996;224:183-188.
12. Inoue H, Mori M, Li J, et al. Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes. Int J Cancer. 1995;63:523-526.
13. Chomczynnski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-PhOH-chloroform extraction. Anal Biochem. 1987;162: 156-159.
14. Mori M, Mimori K, Inoue H, et al. Detection of cancer micrometastasis in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995;55:3417-3420.
15. Tokunaga H, Nakamura Y, Sakata K, et al. Enhanced expression of a gluceraldehyde-3-phosphate dehydrogenase gene in human lung cancer. Cancer Res. 1987;47:5616-5619.
16. Traversari C, Van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med. 1992;176:1453-1457.
17. Van der Bruggen P, Szikora JP, Boel P, et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur J Immunol. 1994;24:2134-2140.
18. Van der Bruggen P, Bastin J, Gajewski T, et al. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol. 1994;24:3038-3043.
19. Coulie PG, Weynants P, Lehmann F, et al. Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. J Immunother. 1993;14:104-109.
20. Russo V, Traversari C, Verrecchia A, Mottolese M, Natali PG, Bordignon C. Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J Cancer. 1995;64:216-221.
21. Tanaka F, Fujie T, Go H, et al. Efficient induction of antitumor cytotoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro. Cancer Immunol Immunother. 1997;44:21-26.
22. Mori M, Mimori K, Tanaka F, Ueo H, Sugimachi K, Akiyoshi T. Molecular diagnosis of circulating cancer cells using MAGE gene assay. JAMA. 1997;278: 476-477. Letter.